Radioiodinated Naphthylalanine Derivatives Targeting Pancreatic Beta Cells in Normal and Nonobese Diabetic Mice

被引:4
作者
Amartey, John K. [1 ]
Shi, Yufei [2 ]
Al-Jammaz, Ibrahim [1 ]
Esguerra, Celestina [1 ]
Al-Otaibi, Basem [1 ]
Al-Mohanna, Futwan [3 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cyclotron & Radiopharmaceut Dept, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia
关键词
D O I
10.1155/2008/371716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An imaging method capable of using a signal from pancreatic beta cells to determine their mass would be of immense value in monitoring the progression of diabetes as well as response to treatment. Somatostatin receptors (SSTRs) are expressed on beta cells and are a potential target for imaging. The main objective of this study was to investigate whether pancreatic beta cells are a target for radiolabeled naphthylalanine derivatives. The molecules were subjected to in vitro and ex vivo evaluations. Pancreatic uptake of radioactivity was lower in nonobese diabetic (NOD) mice than normal mice at all time points investigated (P < .05) and correlated with the number of islets in tissue sections of both control and NOD mice. Immunohistochemical and confocal fluorescent microscopic studies showed colocalization of insulin and the conjugate radioligand in the pancreas. The results demonstrated that pancreatic uptake is receptor-mediated, and that beta cells are the primary target. Copyright (C) 2008 John K. Amartey et al.
引用
收藏
页数:8
相关论文
共 38 条
[1]   Synthesis and evaluation of radiolodinated substituted β-naphthylalanine as a potential probe for pancreatic β-cells imaging [J].
Amartey, JK ;
Esguerra, C ;
Al-Jammaz, I ;
Parhar, RS ;
Al-Otaibi, B .
APPLIED RADIATION AND ISOTOPES, 2006, 64 (07) :769-777
[2]  
ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
[3]   Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes [J].
Barone, R ;
Procaccini, E ;
Chianelli, M ;
Annovazzi, A ;
Fiore, V ;
Hawa, M ;
Nardi, G ;
Ronga, G ;
Pozzilli, P ;
Signore, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (05) :503-508
[4]   Endocrine pancreas plasticity under physiological and pathological conditions [J].
Bernard-Kargar, C ;
Ktorza, A .
DIABETES, 2001, 50 :S30-S35
[5]   Binding properties of somatostatin receptor subtypes [J].
Bruns, C ;
Raulf, F ;
Hoyer, D ;
Schloos, J ;
Lubbert, H ;
Weckbecker, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (08) :17-20
[6]   β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].
Butler, AE ;
Janson, J ;
Bonner-Weir, S ;
Ritzel, R ;
Rizza, RA ;
Butler, PC .
DIABETES, 2003, 52 (01) :102-110
[7]   The development of technetium-99m-labelled interleukin-2: A new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases [J].
Chianelli, M ;
Signore, A ;
Fritzberg, AR ;
Mather, SJ .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (06) :579-586
[8]   Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol [J].
Clark, PB ;
Gage, HD ;
Brown-Proctor, C ;
Buchheimer, N ;
Calles-Escandon, J ;
Mach, RH ;
Morton, KA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (02) :258-260
[9]   Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse [J].
Fagan, SP ;
Azizzadeh, A ;
Moldovan, S ;
Ray, MK ;
Adrian, TE ;
Ding, XZ ;
Coy, DH ;
Brunicardi, FC .
SURGERY, 1998, 124 (02) :254-258
[10]  
Hwang D. R., 2003, Journal of Labelled Compounds and Radiopharmaceuticals, V46, pS352